FAI Advisors, Inc.’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$693K Buy
2,619
+126
+5% +$33.2K 0.27% 69
2026
Q2
$633K Sell
2,493
-74
-3% -$17.2K 0.25% 79
2026
Q1
$627K Buy
2,567
+60
+2% +$14K 0.28% 68
2025
Q4
$519K Sell
2,507
-296
-11% -$58.5K 0.23% 80
2025
Q3
$520K Buy
2,803
+192
+7% +$32.9K 0.23% 76
2025
Q2
$399K Buy
2,611
+43
+2% +$6.61K 0.2% 91
2025
Q1
$426K Sell
2,568
-121
-4% -$18.9K 0.23% 82
2024
Q4
$389K Buy
+2,689
New +$417K 0.17% 92

Other funds holding JNJ

FAI Advisors, Inc.'s JNJ Position: Q3 2026 in Review

FAI Advisors, Inc. increased its Johnson & Johnson (JNJ) stake by 5.1% in Q3 2026, buying an estimated $33.2K and bringing the position to 2,619 shares worth $693K. The position accounts for 0.27% of the portfolio, ranked #69.

FAI Advisors, Inc. first reported a position in JNJ in Q4 2024 and has held it in 8 quarters since. 1,846 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • FAI Advisors, Inc. held 2,619 shares of Johnson & Johnson worth $693K as of Q3 2026.
  • FAI Advisors, Inc. bought 126 Johnson & Johnson shares in Q3 2026, an estimated $33.2K.
  • Johnson & Johnson made up 0.27% of FAI Advisors, Inc.'s portfolio in Q3 2026, its #69 holding.
  • FAI Advisors, Inc. first reported a position in Johnson & Johnson in Q4 2024 and has held it in 8 quarters since.
  • 1,846 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on FAI Advisors, Inc.'s 13F filing for Q3 2026, filed 27 Oct 2026.